All Stories

  1. Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases
  2. Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation
  3. Reconstitution of T-Cell Subsets Following Thymoglobulin-Induced Depletion in High Immunologic Risk and Donation After Cardiac Death Renal Transplant Recipients
  4. Bidirectional graft-host hematological traffic in liver transplantation
  5. The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation
  6. Anti-donor immunoglobulin G subclass in liver transplantation
  7. Antibodies and liver transplantation
  8. Long term follow-up after liver transplantation from a JAK2 mutation positive donor
  9. Fatal graft versus host hemolytic reaction from Rhesus compatible mismatched liver transplantation
  10. After the war is over: the role of General Sir Arthur Currie in the development of academic medicine in Canada
  11. La tyrannie de la question sur le score de douleur postopératoire
  12. Tyranny of the pain score question after surgery
  13. The effectiveness of junctional tourniquets
  14. GDF15 Regulates Malat-1 Circular RNA and Inactivates NFκB Signaling Leading to Immune Tolerogenic DCs for Preventing Alloimmune Rejection in Heart Transplantation
  15. Techniques – Orthotopic kidney transplantation in patients with diseased inferior vena cavas
  16. Hyperkalemia and Dialysis in the Deployed Setting
  17. Provincially administered universal pharmacare programs require a secure, affordable drug supply: A matter of national security?
  18. Les régimes universels d’assurance médicaments provinciaux doivent pouvoir s’appuyer sur un approvisionnement sûr et abordable : Question de sécurité nationale?
  19. Transplantation of pediatric renal allografts from donors less than 10 kg
  20. Massacre of Canadian Army Medical Corps personnel after the sinking of HMHS Llandovery Castle and the evolution of modern war crime jurisprudence
  21. Medical response to the declaration of the First World War: The case of Edwin Seaborn
  22. Article importance: Processes to evaluate the success of published articles are subjective
  23. Degré d’importance des articles : Les processus d’évaluation des articles publiés sont subjectifs
  24. The Canadian Army Medical Corps affair of 1916 and Surgeon General Guy Carleton Jones
  25. Long-term results of protocol kidney biopsy directing steroid withdrawal in simultaneous pancreas-kidney transplant patients
  26. Dr. Louis Kristal at 100: witness to the evolution of surgery in Canada
  27. Continuing a long tradition: the Canadian Journal
  28. First Canadian experience with donation after cardiac death simultaneous pancreas and kidney transplants
  29. Calgary, Edmonton and the University of Alberta: the extraordinary medical mobilization by Canada’s newest province
  30. Retroperitoneal Compartment Syndrome in Renal Transplantation: How to Salvage the Graft?
  31. The future of resuscitative endovascular balloon occlusion in combat operations
  32. Toward a “New School” of surgical research
  33. Vers un « mouvement de l’éducation nouvelle » de recherche en chirurgie
  34. Dual en bloc technique for adult renal transplantation
  35. Injury profile suffered by targets of antipersonnel improvised explosive devices: prospective cohort study
  36. Doceo ergo sum: mentoring surgeons
  37. Somewhere in France (9 April 17): a centenary review of medical arrangements at Vimy Ridge
  38. Over-expression of growth differentiation factor 15 (GDF15) preventing cold ischemia reperfusion (I/R) injury in heart Transplantation through Foxo3a signaling
  39. Les avantages et les risques d’exiger que les chercheurs partagent leurs données
  40. Western University (No. 10 Canadian Stationary Hospital and No. 14 Canadian General Hospital): a study of medical volunteerism in the First World War
  41. Datum isn’t; data are
  42. De l’usage du pluriel (ou non) du mot « data »
  43. Heparin infusion in simultaneous pancreas and kidney transplantation reduces graft thrombosis and improves graft survival
  44. Hypertonic salt solution for peri-operative fluid management
  45. In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents
  46. Caregiver fatigue and surrogate end-of-life decision making
  47. La fatigue des aidants et la prise de décisions en fin de vie par autrui
  48. L’apprentissage interspécialités à l’ère de la formation basée sur les compétences
  49. Élever les normes de production de rapports de recherche chirurgicale pour accroître leur impact
  50. Raising the standard of surgical reporting to increase its impact
  51. Cervical spine injury in dismounted improvised explosive device trauma
  52. Hypothermic machine perfusion improves Doppler ultrasonography resistive indices and long-term allograft function after renal transplantation: a single-centre analysis
  53. La commémoration médicale
  54. Medical memorialization
  55. Donation after Cardiac Death Pediatric En Bloc Renal Transplantation
  56. La chirurgie chez le patient atteint de la maladie à virus Ebola
  57. Surgery in patients with Ebola virus disease
  58. A model for deceased-donor transplant queue waiting times
  59. No specialty alone: the Wilder Penfield strategy
  60. Aucune spécialité n’est une île : la stratégie de Wilder Penfield
  61. L’éducation par les loisirs
  62. Education through recreation
  63. A queuing model to address waiting time inconsistency in solid-organ transplantation
  64. The past and future of the generalist general surgeon
  65. Reuse of liver grafts following the brain death of the initial recipient
  66. Consensus ad idem : une démarche pour la formulation de déclarations de consensus
  67. Consensus ad idem: a protocol for development of consensus statements
  68. Scarpa’s fascia and clinical signs: the role of the membranous superficial fascia in the eponymous clinical signs of retroperitoneal catastrophe
  69. Absence of the genicular arterial anastomosis as generally depicted in textbooks
  70. Treatment of rectal war wounds
  71. Canadian contribution to the ACS
  72. Role of persistent processus vaginalis in hydroceles found in a tropical population
  73. Renal Perfusion Pump Vs Cold Storage for Donation After Cardiac Death Kidneys: A Systematic Review
  74. Slow birth of new-wave medical journalism
  75. A Novel In Vivo siRNA Delivery System Specifically Targeting Liver Cells for Protection of ConA-Induced Fulminant Hepatitis
  76. Management of chest tubes after pulmonary resection: a systematic review and meta-analysis
  77. 1 Canadian Field Hospital in Haiti: surgical experience in earthquake relief
  78. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts
  79. Learning surgically oriented anatomy in a student-run extracurricular club: An education through recreation initiative
  80. Short- and long-term outcomes of third liver transplantation at single centre
  81. Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial
  82. The Life of John Wishart (1850–1926): Study of an Academic Surgical Career Prior to the Flexner Report
  83. The Role 3 Multinational Medical Unit at Kandahar Airfield 2005–2010
  84. Utilization profile of the trauma intensive care unit at the Role 3 Multinational Medical Unit at Kandahar Airfield between May 1 and Oct. 15, 2009
  85. Causes of Death in Canadian Forces Members Deployed to Afghanistan and Implications on Tactical Combat Casualty Care Provision
  86. Increased Risk of Severe Recurrence of Hepatitis C Virus in Liver Transplant Recipients of Donation After Cardiac Death Allografts
  87. Giant Cystic Pheochromocytoma Containing High Concentrations of Catecholamines and Metanephrines
  88. Drills and exercises: the way to disaster preparedness
  89. A pioneer of urologic surgery from a small town in Ontario, Canada: A tribute to Abraham Groves (1847 - 1935)
  90. Management of Devastating Ocular Trauma - Experience of Maxillofacial Surgeons Deployed to a forward Field Hospital
  91. In-Theater Peritoneal Dialysis for Combat-Related Renal Failure
  92. Hypertonic saline for peri-operative fluid management
  93. Substitution of adeno-associated virus Rep protein binding and nicking sites with human Chromosome 19 sequences
  94. Long-term outcomes of emergency liver transplantation for acute liver failure
  95. H1N1-related SIRS?
  96. Analysis of DNA Binding by a Eubacterial Zinc Finger Transcription Factor
  97. Recombinant activated factor VII in the treatment of non-haemophilia patients: physician under-reporting of thromboembolic adverse events
  98. Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors
  99. Perfusion of Renal Allografts With Verapamil Improves Graft Function
  100. Use of Recombinant Activated Factor VII in Patients Without Hemophilia
  101. Waiting for liver transplantation in Canada: waitlist history 2000–2004 and sensitivity analysis for the future
  102. Prospective Comparison of Magnetic Resonance Angiography with Selective Renal Angiography for Living Kidney Donor Assessment
  103. Is Serum Hepcidin Causative in Hemochromatosis? Novel Analysis from a Liver Transplant with Hemochromatosis
  104. Cholecystectomy deferral in patients with endoscopic sphincterotomy
  105. Re-exposure to Mismatched HLA Class I Is a Significant Risk Factor for Graft Loss: Multivariable Analysis of 259 Kidney Retransplants
  106. Preferential Integration of Adeno-Associated Virus Type 2 into a Polypyrimidine/Polypurine-Rich Region within AAVS1
  107. The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference
  108. Intracerebral co-transplantation of liposomal tacrolimus improves xenograft survival and reduces graft rejection in the hemiparkinsonian rat
  109. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence
  110. Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events
  111. Treatment of renal transplant complications with a mesh hood fascial closure technique
  112. Cyclosporin versus tacrolimus for liver transplanted patients
  113. Cholecystectomy deferral in patients with endoscopic sphincterotomy
  114. Cyclosporin versus Tacrolimus as Primary Immunosuppressant After Liver Transplantation: A Meta-Analysis.
  115. Intravenous Immunoglobulin as a Treatment for BK Virus Associated Nephropathy: One-Year Follow-Up of Renal Allograft Recipients
  116. Catastrophic microangiopathy induced by high-titre factor VIII inhibitors after liver transplantation for haemophilia A with cirrhosis
  117. Association of recanalization of the left umbilical vein with umbilical hernia in patients with liver disease
  118. Clinical kidney transplantation: a 50th anniversary review of the first reported series
  119. Correction of Factor XI Deficiency by Liver Transplantation
  120. Is topical treatment of osteoarthritis site-specific?
  121. A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipients
  122. Cyclosporin versus tacrolimus for liver transplanted patients
  123. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation
  124. Duodenal dearterialization and stapling for severe hemorrhage from duodenal varices with portal vein thrombosis
  125. Modification of xenoantigens on porcine erythrocytes for xenotransfusion
  126. Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation
  127. Immunoglobulin-G subclass antidonor reactivity in transplant recipients
  128. Prospective evaluation of the role of quantitative Doppler ultrasound surveillance in liver transplantation
  129. A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada, and the United States
  130. In vitro studies regarding the feasibility of bovine erythrocyte xenotransfusion
  131. Transplantation in Canada: report of the Canadian Organ Replacement Register
  132. Mesh hood fascial closure in renal allograft compartment syndrome
  133. Liver transplantation for primary sclerosing cholangitis
  134. Long-term follow-up of pediatric en bloc renal transplantation
  135. Survival after liver transplantation for hepatocellular carcinoma
  136. Pharmacogenomics in liver transplantation
  137. Identification of Upstream Sequences Essential for Activation of a Bacteriophage P2 Late Promoter
  138. Early steroid withdrawal after liver transplantation: The canadian tacrolimus versus microemulsion cyclosporin a trial: 1-year follow-up
  139. Editorial: Management of umbilical hernia in patients with advanced liver disease
  140. Purification and In Vitro Characterization of the Serratia marcescens NucC Protein, a Zinc-Binding Transcription Factor Homologous to P2 Ogr
  141. The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome
  142. Use of a Pelvic Kidney for Living Transplantation: Case Report and Review of the Literature
  143. New Immunosuppressants in Clinical Trial
  144. Predicting behavior of immunosuppressants in liver transplantation
  145. Evaluating porcine RBC and platelet alpha-galactosyl expression
  146. Predicting behavior of immunosuppressants in liver transplantation
  147. A Clinical Pharmacokinetic Study of Tacrolimus and Sirolimus Combination Immunosuppression Comparing Simultaneous to Separated Administration
  148. Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model
  149. Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model1
  150. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study
  151. Liposomal Tacrolimus Administered Systemically and within the Donor Cell Suspension Improves Xenograft Survival in Hemiparkinsonian Rats
  152. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus
  153. Circulating endothelial cells after transplantation
  154. Repopulation of liver endothelium by bone-marrow-derived cells
  155. Canadian multicentre trial of tacrolimus/azathioprine/steroids versus tacrolimus/mycophenolate mofetil/steroids versus neoral/mycophenolate mofetil/steroids in renal transplantation
  156. De novo use of low-dose tacrolimus and sirolimus in liver transplantation
  157. Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function
  158. Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients
  159. CONVERSION TO RAPAMYCIN IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS: REPORT OF AN INITIAL EXPERIENCE1
  160. Abdominal fluid collection after laparoscopic cholecystectomy
  161. IS ROUTINE URETERIC STENTING NEEDED IN KIDNEY TRANSPLANTATION? A RANDOMIZED TRIAL
  162. A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels
  163. Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants
  164. PROLONGATION OF ALLOGRAFT SURVIVAL BY Nippostrongylus brasiliensis IS ASSOCIATED WITH DECREASED ALLOSPECIFIC CYTOTOXIC T LYMPHOCYTE ACTIVITY AND DEVELOPMENT OF T CYTOTOXIC CELL TYPE 2 CELLS1
  165. Sirolimus-tacrolimus combination immunosuppression
  166. Alloimmune Thrombocytopenia after Organ Transplantation
  167. Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies
  168. POTENTIAL FOR IMPROVED THERAPEUTIC INDEX OF FK506 IN LIPOSOMAL FORMULATION DEMONSTRATED IN A MOUSE CARDIAC ALLOGRAFT MODEL1,2
  169. THE MORBIDITY OF PROLONGED WOUND DRAINAGE AFTER KIDNEY TRANSPLANTATION
  170. THE MORBIDITY OF PROLONGED WOUND DRAINAGE AFTER KIDNEY TRANSPLANTATION
  171. Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity
  172. Comparative efficacy of liposomal FK506 with FK506
  173. Liposomal tacrolimus and intestinal drug concentration
  174. Variation in porcine red blood cell α-galactosyl expression and agglutination by human serum
  175. Cost of Liver Transplantation Using Tacrolimus
  176. Liposomal Tacrolimus: Drug Migration Within Blood Compartments
  177. Aortic valve grafts in the rat: Evidence for rejection
  178. Prevention of postsurgical adhesions with N,O-carboxymethyl chitosan: Examination of the most efficacious preparation and the effect of N,O-carboxymethyl chitosan on postsurgical healing
  179. Financial impact of cold ischemia time in renal transplantation
  180. Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine
  181. Prevention of experimental postoperative peritoneal adhesions by N,O-carboxymethyl chitosan
  182. Importance of Minor Histocompatibility Antigens in the Development of Allograft Arteriosclerosis
  183. Induction of Transplantation Tolerance by Feeding or Portal Vein Injection Pretreatment of Recipient with Donor Cells
  184. PROLONGATION OF RAT KIDNEY ALLOGRAFT SURVIVAL BY NEMATODES1,2
  185. Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation
  186. Development of a mouse aortic transplant model of chronic rejection
  187. Normal fasting volume and postprandial emptying of the denervated donor gallbladder in liver transplant recipients
  188. Harpoon extraction of a common bile duct stone impacted at the ampulla of Vater with needle-knife sphincterotome
  189. Surgical technique for combined liver/intestine transplantation in rats
  190. VENTILATION/PERFUSION AFTER LIVER RANSPLANTATION IN DECOMPENSATED CIRRHOSIS
  191. Effect of fibrin sealant on the healing colonic anastomosis